Diacomit (stiripentol)

Alan Pharmaceuticals is the Marketing Authorisation Holder for Diacomit (stiripentol) in Great Britain.

It is available in the following presentations:

  • DIACOMIT (stiripentol) 250mg capsules, for oral use
  • DIACOMIT (stiripentol) 250mg powder, for oral suspension
  • DIACOMIT (stiripentol) 500mg capsules, for oral use
  • DIACOMIT (stiripentol) 500mg powder, for oral suspension

Diacomit (stiripentol) Product Information

The Patient Information Leaflet and Summary of Product Characteristics for GB licensed packs can be accessed here.

The link will take you to the electronic Medicines Compendium (eMC) website which is a non-Alan Pharmaceuticals website. Alan Pharmaceuticals does not recommend, endorse or accept liability for sites controlled by third-parties.

The Patient Information Leaflet and Summary of Product Characteristics for EMA licensed packs can be accessed here.

This link will take you to the European Medicines Agency (EMA) website which is a non-Alan Pharmaceuticals website. Alan Pharmaceuticals does not recommend, endorse or accept liability for sites controlled by third- parties.


European Public Assessment Report

Please see the European Public Assessment Report here.

This link will take you to the European Medicines Agency (EMA) website which is a non-Alan Pharmaceuticals website. Alan Pharmaceuticals does not recommend, endorse or accept liability for sites controlled by third- parties.


Diacomit (stiripentol) Adverse Drug Reaction Reporting and Medical Information

You can find the contact details on our Contact Us page.


© Alan Pharmaceuticals 2023 ..l.. Modern Slavery Statement ..l.. Contact Us